News

Larkspur Biosciences to Present New Mechanistic Data on the Role of Pin1 in Modulating the Fibroblast – Cancer Axis at SITC 2023

Oct 25, 2023•Press Release

Research emphasizes the significant role of Pin1 in influencing critical cancer mechanisms to drive a pro-immune response, re...

Larkspur Biosciences Announces First-in-Class Program Targeting Novel B Cell Checkpoint

Jun 26, 2023•Press Release

Research foundational to Larkspur’s newly disclosed TIM-1 program published by founder Vijay K. Kuchroo in Nature Watertown...

Larkspur Biosciences to Participate in the 2023 BIO International Convention

May 30, 2023•Press Release

Watertown, MA – May 30, 2023 — Larkspur Biosciences, a biotechnology company building the next precision immunotherap...

Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer

May 23, 2023•Press Release

Addressing the Key Bottlenecks in the Tumor Microenvironment That Allow a Tumor to Subvert the Immune System Financing Co-led...